Updated Diagnostic Criteria for Diabetic Ketoacidosis
The American Diabetes Association defines DKA by requiring all three components simultaneously: blood glucose >250 mg/dL, venous pH <7.3, and serum bicarbonate <15 mEq/L, with elevated blood ketones (preferably β-hydroxybutyrate). 1
However, the traditional glucose threshold has been de-emphasized in recent guidelines due to the increasing recognition of euglycemic DKA, particularly in patients on SGLT-2 inhibitors. 2, 3
Core Diagnostic Parameters
Glucose Threshold
- Blood glucose >250 mg/dL remains the classic criterion, though euglycemic DKA (glucose <250 mg/dL or even <200 mg/dL) is increasingly recognized, especially with SGLT-2 inhibitor use, starvation, pregnancy, chronic liver disease, or alcohol use. 1, 4, 2
- The glucose threshold should not be used as an absolute rule-out criterion; clinicians must maintain high suspicion for DKA even with normal or near-normal glucose levels. 2, 3
pH and Acid-Base Status
- Venous pH <7.3 is required for diagnosis and reflects the severity of ketoacidosis. 1, 5
- Venous pH is preferred over arterial pH for monitoring after initial diagnosis, as it adequately tracks acidosis resolution and avoids repeated arterial punctures. 5
- The venous pH is typically 0.03 units lower than arterial pH. 5
Bicarbonate Level
- Serum bicarbonate <15 mEq/L indicates metabolic acidosis and is a required diagnostic criterion. 1, 5
- For DKA resolution, bicarbonate must rise to ≥18 mEq/L. 1, 5
Anion Gap
- Calculate anion gap as [Na⁺] - ([Cl⁻] + [HCO₃⁻]), which should be >10-12 mEq/L in DKA. 1, 5
- The anion gap helps distinguish DKA from other causes of metabolic acidosis and should be monitored every 2-4 hours during treatment. 1, 5
- For DKA resolution, anion gap must normalize to ≤12 mEq/L. 1
Ketone Measurement
- Direct blood β-hydroxybutyrate measurement is the gold standard for both diagnosis and monitoring, not urine ketones or nitroprusside-based tests. 1, 5
- β-hydroxybutyrate is the predominant and strongest ketoacid in DKA; nitroprusside tests only detect acetoacetate and acetone, missing the majority of the ketone burden. 1, 5
- Normal fasting ketone levels are <0.5 mmol/L; DKA resolution requires β-hydroxybutyrate to fall below this threshold. 5
- Critical pitfall: Urine ketones lag behind serum ketone clearance and may paradoxically worsen during treatment as β-hydroxybutyrate converts to acetoacetate, falsely suggesting treatment failure. 1, 5
Severity Classification
The American Diabetes Association stratifies DKA severity to guide monitoring intensity and predict prognosis: 1, 5
Mild DKA
Moderate DKA
Severe DKA
- Venous pH <7.00
- Bicarbonate <10 mEq/L
- Anion gap >12 mEq/L
- Stuporous or comatose mental status
- Associated with higher morbidity and mortality; often requires intensive monitoring including central venous and intra-arterial pressure monitoring 1, 5
Essential Laboratory Workup
Immediate Initial Tests
- Complete metabolic panel: sodium, potassium, chloride, bicarbonate, BUN, creatinine, glucose 1
- Venous blood gas: pH, pCO₂, bicarbonate 1
- Serum β-hydroxybutyrate (not urine ketones) 1, 5
- Complete blood count with differential 1, 5
- Urinalysis 1, 5
- Serum osmolality 1, 5
- Electrocardiogram to assess for cardiac effects of electrolyte abnormalities 6, 1
- HbA1c to distinguish acute versus chronic poor glycemic control 5
Corrected Sodium Calculation
- Add 1.6 mEq/L for each 100 mg/dL glucose above 100 mg/dL to the measured sodium value to calculate corrected serum sodium. 6, 5
- This correction guides subsequent fluid selection during treatment. 6, 5
Additional Tests When Indicated
- Bacterial cultures (urine, blood, throat) if infection is suspected 6, 5
- Chest X-ray if clinically indicated 6
- Blood lactate to distinguish lactic acidosis from DKA 5
- Amylase, lipase, hepatic transaminases, troponin, creatine kinase to identify complications 2
- Toxicology screen if toxic ingestion (salicylate, methanol, ethylene glycol) is suspected 1, 5
Differential Diagnosis Considerations
DKA must be distinguished from other causes of high anion gap metabolic acidosis: 1, 5
- Lactic acidosis: measure blood lactate 1, 5
- Toxic ingestions: salicylate, methanol, ethylene glycol—obtain specific toxicology tests 1, 5
- Chronic renal failure: check BUN and creatinine 1, 5
- Alcoholic ketoacidosis: clinical history, typically lower glucose levels 5
- Starvation ketosis: clinical history, less severe acidosis, lower bicarbonate 1, 5
Monitoring During Treatment
- Check blood glucose, serum electrolytes (especially potassium), venous pH, bicarbonate, anion gap, BUN, creatinine, and osmolality every 2-4 hours until metabolically stable. 6, 1, 5
- Monitor β-hydroxybutyrate every 2-4 hours during treatment, as ketonemia typically takes longer to clear than hyperglycemia. 1, 5
- Serum potassium must be checked before initiating insulin and monitored every 2-4 hours, as insulin drives potassium intracellularly and can precipitate life-threatening hypokalemia. 6, 5
Resolution Criteria
DKA is resolved only when ALL of the following are met simultaneously: 1, 5
- Glucose <200 mg/dL
- Venous pH >7.3
- Serum bicarbonate ≥18 mEq/L
- Anion gap ≤12 mEq/L
- β-hydroxybutyrate <0.5-1.0 mmol/L 5
Critical pitfall: Do not discontinue insulin therapy prematurely before complete resolution of ketoacidosis, even if glucose normalizes, as this is the most common cause of recurrent DKA. 1, 5
Initial Management Recommendations
Fluid Resuscitation
- Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour for the first hour (approximately 1-1.5 L in an average adult) to restore intravascular volume. 6, 5
- Total body water deficit is typically 6-9 liters; plan replacement over 24 hours. 5
- After the first hour, switch to 0.45% NaCl at 4-14 mL/kg/hour if corrected sodium is normal or elevated, or continue 0.9% NaCl if corrected sodium is low. 6, 5
- When plasma glucose falls to 250 mg/dL, change IV fluids to 5% dextrose with 0.45-0.75% NaCl while maintaining the insulin infusion rate. 6, 5
Potassium Management (Class A Evidence)
- Absolute contraindication: Do not start insulin if serum potassium is <3.3 mEq/L; aggressively replete potassium first to prevent fatal cardiac arrhythmias. 6, 5
- If potassium is 3.3-5.5 mEq/L, insulin may be started; add 20-30 mEq/L potassium to IV fluids (using 2/3 potassium chloride or acetate and 1/3 potassium phosphate) once adequate urine output is confirmed. 6, 5
- If potassium is >5.5 mEq/L, start insulin immediately but delay potassium supplementation until the level falls below 5.5 mEq/L. 6, 5
- Target serum potassium 4.0-5.0 mEq/L throughout treatment. 6, 5
Insulin Therapy
- For moderate-to-severe DKA, give an IV bolus of 0.1 units/kg regular insulin followed by continuous infusion at 0.1 units/kg/hour. 6, 5
- In pediatric patients, omit the bolus and start continuous infusion at 0.05-0.1 units/kg/hour to reduce cerebral edema risk. 6, 5
- Target glucose decline of 50-75 mg/dL per hour; if glucose does not fall by 50 mg/dL in the first hour, verify adequate hydration and double the insulin infusion rate hourly until steady decline is achieved. 6, 5
- Never discontinue insulin when glucose normalizes; continue infusion to clear ketones and prevent recurrent DKA. 6, 5
Transition to Subcutaneous Insulin
- Administer long-acting basal insulin (glargine or detemir) 2-4 hours BEFORE stopping the IV insulin infusion to prevent rebound hyperglycemia and DKA recurrence. 6, 5
- Continue IV insulin for an additional 1-2 hours after the subcutaneous basal dose to ensure adequate absorption. 6, 5
Bicarbonate Therapy
- Routine bicarbonate administration is NOT recommended for DKA management; it provides no benefit in acidosis resolution time or hospital length of stay. 5
- Consider bicarbonate only if pH <6.9 after initial fluid resuscitation: give 100 mmol sodium bicarbonate diluted in 400 mL sterile water infused at 200 mL/hour. 6, 5